GlassScriptPhysician profile
Jonathan N Kruh
NPI 1801191184
$9,691.34
in general payments reported to CMS, 2019-2025
28 companies · $2,447 in 2025
The $2,447 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $804 · 2020: $435 · 2021: $1,044 · 2022: $1,359 · 2023: $1,958 · 2024: $1,645 · 2025: $2,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,847 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,846.88 |
| Education | $203.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $3,184.16 | 2020-2025 | Acthar |
| Glaukos Corporation | $922.04 | 2021-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Sun Pharmaceutical Industries INC. | $726.79 | 2019-2025 | Cequa |
| Alcon Vision LLC | $646.35 | 2021-2025 | Wavelight Refractive Suite, Wavelight Ex500 Excimer Laser, Eysuvis |
| Biotissue Holdings INC. | $559.48 | 2019-2025 | |
| Aerie Pharmaceuticals, INC. | $525.30 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $325.46 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $320.16 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $316.76 | 2022-2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $270.98 | 2024-2025 | Vevye, Ilevro |
| Abbvie INC. | $260.27 | 2023-2025 | |
| Dompe US, INC. | $249.39 | 2022-2025 | Oxervate |
| Rxsight INC | $198.31 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Kala Pharmaceuticals, INC. | $190.53 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $131.76 | 2019-2025 | Tecnis Iol, Tecnis Iol |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avedro INC. | $126.30 | 2019 | |
| Shire North American Group INC | $120.53 | 2019 | |
| Amgen INC. | $118.47 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $97.71 | 2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $68.69 | 2021-2023 | |
| Eyepoint US, INC. | $64.51 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.81 | 2019-2021 | |
| Allergan, INC. | $43.27 | 2021-2022 | |
| Beaver-Visitec International, INC. | $43.14 | 2021 | |
| Eyevance Pharmaceuticals LLC | $40.63 | 2020-2022 | |
| New World Medical,INC. | $40.17 | 2020-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Carl Zeiss Meditec Cataract Technology INC. | $36.65 | 2019 | |
| Horizon Therapeutics Plc | $16.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Kruh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.